Details of OGTR monitoring and compliance activities during the quarter ended 31 March 2024.
This Communiqué covers matters considered at the 59th meeting of the Gene Technology Technical Advisory Committee (4 March 2024).
This issue focuses on the PC2 Guidelines and the OGTR Online Services Portal.
Use this form to notify the OGTR of commencement or completion of minor works to PC1 or PC2 certified facilities.
Limited and controlled release of canola genetically modified for increased abiotic stress tolerance.
Misinformation has been circulating regarding mRNA COVID-19 vaccines and gene therapy. The following statement addresses this misinformation.
Commercial release of cotton genetically modified for herbicide tolerance (MON 88701)
Clinical trial for the treatment of mycobacterial infections using bacteriophages
This Communique covers matters considered at the 38th videoconference of the Gene Technology Technical Advisory Committee (17 June 2024).
Details of OGTR monitoring and compliance activities during the quarter ended 30 June 2024.